In LUAD patients, almost all KRAS G12-mutant cancer patients were predicted to be KRAS dependent, albeit along a spectrum (Fig 5A and 5B), and we found that the prediction scores were only correlated with some TCGA subtypes in the KRAS WT tumors [29]. Here, KRAS is linked to cancer.